Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04827992 · ClinicalTrials.gov registry record · NA
Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT04827992: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04827992 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04827992, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
This study will use a randomized controlled design to test whether medical marijuana use by adults on high-dose chronic opioid therapy (COT) for chronic non-cancer pain is associated with reduced opioid dose and improved pain intensity and interference when added to a 24-week behavioral intervention (POTS).
Interventions
- DRUG Cannabis
- BEHAVIORAL Prescription Opioid Taper Support (POTS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2021-08-23 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04827992
The ClinicalTrials.gov registry entry for NCT04827992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cannabis is the first listed.
NCT04827992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04827992 about?
NCT04827992 is a clinical study titled "Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain". This study will use a randomized controlled design to test whether medical marijuana use by adults on high-dose chronic opioid therapy (COT) for chronic non-cancer pain is associated with reduced opioid dose and improved pain intensity and interference when added to a 24-week behavioral intervention...
What is the current status of trial NCT04827992?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2021-08-23. Estimated completion is 2025-10-31.
What interventions are being tested in trial NCT04827992?
The interventions under investigation include: Cannabis (DRUG), Prescription Opioid Taper Support (POTS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04827992?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.